Search Within

Anita S Bowman

Formats
  1. Meeting Abstract (23)
  2. Journal Article (21)
Groups
  1. Department of Pathology and Laboratory Medicine (43)
  2. GSK Faculty (40)
  3. Human Oncology and Pathogenesis Program (38)
  4. Department of Medicine (30)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (25)
  6. Solid Tumor Oncology Division (24)

More Groups

People
  1. Marc Ladanyi (22)
  2. Chad Vanderbilt (21)
  3. Ahmet Zehir (20)
  4. Michael Berger (20)
  5. Maria Arcila (15)
  6. Snjezana Dogan (12)

More People

Years
  1. 2025 (3)
  2. 2024 (5)
  3. 2023 (4)
  4. 2022 (9)
  5. 2021 (4)
  6. 2020 (7)

More Years

Publications
  1. Journal of Molecular Diagnostics (8)
  2. Journal of Clinical Oncology (5)
  3. Laboratory Investigation (5)
  4. Modern Pathology (5)
  5. Nature Communications (3)
  6. Clinical Cancer Research (2)

More Publications

Publishers
  1. Elsevier Science, Inc. (8)
  2. Nature Publishing Group (8)
  3. American Society of Clinical Oncology (7)
  4. American Association for Cancer Research (5)
  5. Nature Research (5)
  6. Wiley Blackwell (2)

More Publishers

Results (44)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical characteristics and outcomes of patients with EGFR-mutant lung cancer with acquired BRAF alterations
    Meeting Abstract

    Sui, J.; Yang, S. R.; Bowman, A. S.; Vankayala, P.; Falcon, C.; Somwar, R.; Drilon, A. E.; Riely, G. J.; Kris, M. G.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC)
    Meeting Abstract

    Keane, F.; Saadat, L.; O'Connor, C.; Chou, J. F.; Brannon, A. R.; Cowzer, D.; Crowley, F.; Debnath, N.; Bowman, A.; Xu, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Prospective clinical genomic profiling of Ewing sarcoma: ERF and FGFR1 mutations as recurrent secondary alterations of potential biologic and therapeutic relevance
    Journal Article

    Ogura, K.; Elkrief, A.; Bowman, A. S.; Koche, R. P.; de Stanchina, E.; Benayed, R.; Mauguen, A.; Mattar, M. S.; Khodos, I.; Meyers, P. A.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • MSK-ACCESS Heme: A cell-free DNA next-generation sequencing assay to identify somatic alterations in patients with lymphoma
    Meeting Abstract

    DiNapoli, S. E.; Spence, C.; Gedvilaite, E.; Bowman, A.; Diosdado, M.; Razumova, A.; Tsui, D.; Salles, G. A.; Batlevi, C.; von Keudell, G.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Validation of a cell-free DNA NGS assay for hematological malignancies
    Meeting Abstract

    Gedvilaite, E.; DiNapoli, S.; Spence, C.; Diosdado, M. S.; Razumova, A.; Bowman, A. S.; Tsui, D. W. Y.; Salles, G.; Batlevi, C. L.; von Keudell, G.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Impact of intratumoral microbiome on immunotherapy treatment outcomes in patients with advanced non-small cell lung cancer
    Meeting Abstract

    Elkrief, A.; Bowman, A.; Rizvi, H.; Hellmann, M.; Riely, G. J.; Schoenfeld, A. J.; Ladanyi, M.; Vanderbilt, C. M.
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Defining novel DNA virus-tumor associations and genomic correlates using prospective clinical tumor/normal matched sequencing data
    Journal Article

    Vanderbilt, C. M.; Bowman, A. S.; Middha, S.; Petrova-Drus, K.; Tang, Y. W.; Chen, X.; Wang, Y.; Chang, J.; Rekhtman, N.; Busam, K. J.; more...
    Journal of Molecular Diagnostics (2022)

    Fulltext@MSK | Save
  • Next-generation sequencing analysis suggests varied multistep mutational pathogenesis for endocrine mucin-producing sweat gland carcinoma with comments on INSM1 and MUC2 suggesting a conjunctival origin
    Journal Article

    Mathew, J. G.; Bowman, A. S.; Saab, J.; Busam, K. J.; Nehal, K.; Pulitzer, M.
    Journal of the American Academy of Dermatology (2022)

    Fulltext@MSK | Save
  • Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center
    Journal Article

    Rosenbaum, E.; Antonescu, C. R.; Smith, S.; Bradic, M.; Kashani, D.; Richards, A. L.; Donoghue, M.; Kelly, C. M.; Nacev, B.; Chan, J. E.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Same-cell co-occurrence of RAS hotspot and BRAF V600E mutations in treatment-naive colorectal cancer
    Journal Article

    Gularte-MeĢrida, R.; Smith, S.; Bowman, A. S.; da Cruz Paula, A.; Chatila, W.; Bielski, C. M.; Vyas, M.; Borsu, L.; Zehir, A.; Martelotto, L. G.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save